Profile photo Caroline Lindemans

Caroline Lindemans

Assistant Professor - medical

Biography

Caroline Lindemans, MD, PhD is a pediatrician, BMT specialist  and pediatric immunologist in the UMC Utrecht. Appointed as a consultant in HCT she has a special  research interest in graft versus host disease, intestinal toxicity, it’s prevention and therapy.  After receiving a KWF fellowship grant she recently worked at Memorial Sloan Kettering Cancer Center in the Research groups of Marcel van den Brink  and Alan Hanash resulting in a first author Nature paper, published December 2015. She has ongoing collaborations with these groups and is currently expanding this line of research in the UMC Utrecht.  Caroline is an active member of various international working committees (e.g. EBMT, CIBMTR: chair of one of the CIBMTR working committees).

Recent publications

Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries Daphne H. Schoenmakers, Fanny Mochel, Laura A. Adang, Jaap Jan Boelens, Valeria Calbi, Erik A. Eklund, Sabine W. Grønborg, Francesca Fumagalli, Samuel Groeschel, Caroline Lindemans, Caroline Sevin, Ludger Schöls, Dipak Ram, Ayelet Zerem, Holm Graessner, Nicole I. Wolf
Orphanet Journal of Rare Diseases, 2024, vol. 19
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management Lucia Laugwitz, Daphne H. Schoenmakers, Laura A. Adang, Stefanie Beck-Woedl, Caroline Bergner, Geneviève Bernard, Annette Bley, Audrey Boyer, Valeria Calbi, Hanka Dekker, Florian Eichler, Erik Eklund, Francesca Fumagalli, Francesco Gavazzi, Sabine W. Grønborg, Peter van Hasselt, Mirjam Langeveld, Caroline Lindemans, Fanny Mochel, Andreas Oberg, Dipak Ram, Elise Saunier-Vivar, Ludger Schöls, Michael Scholz, Caroline Sevin, Ayelet Zerem, Nicole I. Wolf, Samuel Groeschel
European Journal of Paediatric Neurology, 2024, vol. 49, p.141-154
IFNγ induces epithelial reprogramming driving CXCL11-mediated T cell migration Alessandro Cutilli, Suze A Jansen, Francesca Paolucci, Michal Mokry, Enric Mocholi, Caroline A Lindemans, Paul J Coffer
2024
High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant Rick Admiraal, A Birgitta Versluijs, Alwin D R Huitema, Lysette Ebskamp, Amelia Lacna, C T Klaartje de Kanter, Marc B Bierings, Jaap Jan Boelens, Caroline A Lindemans, Stefan Nierkens
Cytotherapy, 2024, vol. 26, p.599-605
High-dose ERT, rituximab, and early HSCT in an infant with Wolman’s disease Siawosh K. Eskandari, Elisabeth G.M. Revenich, Dirk J. Pot, Foekje de Boer, Marc Bierings, Francjan J. van Spronsen, Peter M. van Hasselt, Caroline A. Lindemans, Charlotte M.A. Lubout
New England Journal of Medicine, 2024, vol. 390, p.623-629
Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior Suze A. Jansen, Alessandro Cutilli, Coco de Koning, Marliek van Hoesel, Cynthia L. Frederiks, Leire Saiz Sierra, Stefan Nierkens, Michal Mokry, Edward E.S. Nieuwenhuis, Alan M. Hanash, Enric Mocholi, Paul J. Coffer, Caroline A. Lindemans
iScience, 2024, vol. 27, p.1-19